A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Clinical trial NCT06051409 · RECRUITING
Trial details
- NCT number
- NCT06051409
- Sponsor
- Ascentage Pharma Group Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2027-12-31
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.